Chancellor Reeves Intends Targeted Measures on Living Costs in Upcoming Financial Plan
Treasury head Reeves has stated she is planning "targeted measures to address cost of living pressures" in the forthcoming financial statement.
Speaking to media outlets, she emphasized that curbing inflation is a collective responsibility of both the administration and the Bank of England.
The UK's price growth is projected to be the highest among the G7 industrialized countries this calendar year and the following year.
Possible Energy Bill Measures
Reports indicate the administration could intervene to bring down energy bills, for instance by cutting the present 5% rate of VAT applied on energy supplies.
An additional possibility is to lower some of the regulatory levies presently added to household expenses.
Budgetary Constraints and Analyst Predictions
The administration will obtain the next assessment from the official forecaster, the OBR, on the start of the week, which will clarify how much scope there is for these actions.
The consensus from the majority of experts is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to adhere to her self-imposed debt limits.
Earlier on the same day, estimates suggested there was a £22 billion deficit for the Treasury chief to resolve, which is at the lower end of forecasts.
"There's a collective job between the central bank and the administration to continue tackling some of the sources of price increases," the Chancellor informed the BBC in the US capital, at the conferences of the IMF and global financial institution.
Tax Pledges and International Issues
While much of the focus has been on expected tax increases, the Treasury chief said the most recent figures from the fiscal watchdog had not changed her pledge to manifesto promises not to raise tax levels on earnings tax, VAT or National Insurance.
She blamed an "unpredictable world" with rising geopolitical and trade issues for the Budget revenue measures, likely to be targeted on those "wealthiest."
International Trade Tensions
Addressing concerns about the UK's economic relations with China she said: "Our security interests invariably are paramount."
Last week's statement by Chinese authorities to tighten export controls on critical minerals and other materials that are essential for high-technology manufacturing led American leader Donald Trump to threaten an extra 100% tariff on imports from China, increasing the possibility of an full-scale trade war between the two economic giants.
The US Treasury Secretary labeled the Chinese decision "commercial pressure" and "a global supply chain power grab."
Questioned on considering the US offer to join its conflict with China, the Chancellor said she was "extremely troubled" by China's measures and called on the Beijing authorities "not to put up barriers and limit trade."
She said the action was "damaging for the global economy and causes further challenges."
"It is my opinion there are areas where we need to confront Chinese policies, but there are also significant chances to export to Chinese markets, including financial services and other sectors of the economic system. We've got to get that balance right."
The Treasury chief also confirmed she was collaborating with international partners "regarding our own critical minerals strategy, so that we are less reliant."
NHS Drug Pricing and Funding
The Chancellor also admitted that the price the NHS pays for drugs could rise as a consequence of current talks with the Trump administration and its drugs companies, in exchange for reduced taxes and investment.
Some of the biggest global drug companies have said recently that they are either delaying or canceling operations in the UK, with several attributing the insufficient payments they are receiving.
Recently, the Science Minister said the price the health service spends on medicines would have to rise to halt firms and drug research funding leaving the UK.
Reeves stated to the BBC: "It has been observed because of the payment system, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the manner that they are in other EU nations."
"Our aim is to guarantee that people receiving care from the National Health Service are able to access the best life-saving treatments in the world. And so we are reviewing this situation, and... looking to secure more investment into the UK."